Summarized by Masters of Longevity from PR Newswire.
A news article about a new U.S. hospital system for continuous kidney replacement therapy, explaining its clinical purpose and workflow benefits.
Key Takeaways
- FDA clearance of multiFiltratePRO and approval of dedicated solutions expand continuous kidney replacement therapy options for U.S.
- 21, 2026 /PRNewswire/ -- Fresenius Medical Care, the world's leading provider of products and services for people with kidney disease, today announced the U.S.
- MultiFiltratePRO's integrated technology eliminates the need for separate citrate and calcium pumps, and automatically adjusts as treatment conditions change, making complex treatment easier for hospital intensive care teams to manage.
